EPISODE · Jul 31, 2026 · 4 MIN
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
from Neurology Minute · host American Academy of Neurology
In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial.
Embed this episode
Ready to play
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
No transcript for this episode yet
Similar Episodes
No similar episodes found.